Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nathalie J. Hijmering
Observed names:
Hijmering, Nathalie,
N. Hijmering,
N. J. Hijmering,
N.J. Hijmering,
Nathalie Hijmering,
Nathalie J Hijmering
show all 6
Institutions:
Hovon,
Amsterdam University Medical Centers,
Cancer Center Amsterdam,
Amsterdam UMC Location Vrije Universiteit Amsterdam
Observed institutions:
Maastricht University Medical Centre,
The Netherlands Cancer Institute,
Maastricht University,
Hovon,
Amsterdam University Medical Centers,
Cancer Center Amsterdam,
Vrije Universiteit Amsterdam,
Amsterdam UMC Location Vrije Universiteit Amsterdam
show all 8
ORCID:
0009-0004-3473-0033
Observed ORCID:
0009-0004-3473-0033
OpenAlex ID:
A5076298267
Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast
2018
·
Mintsje de Boer
, Flora E. van Leeuwen
, et al.
·
JAMA Oncology
·
302
PDF
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment
2021
·
Hilma J. van der Horst
, A. Vera de Jonge
, et al.
·
Blood Cancer Journal
·
86
PDF
Benign and malignant tumors in Rubinstein–Taybi syndrome
2018
·
Max V. Boot
, Martine J. van Belzen
, et al.
·
American Journal of Medical Genetics Part A
·
59
PDF
Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman
2017
·
Mintsje de Boer
, Wouter B van der Sluis
, et al.
·
Aesthetic Surgery Journal
·
58
Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma
2020
·
G. Tjitske Los-de Vries
, Mintsje de Boer
, et al.
·
Blood
·
56
PDF
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial
2019
·
Martine E.D. Chamuleau
, Coreline N. Burggraaff
, et al.
·
Haematologica
·
54
PDF
Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast
2020
·
Mintsje de Boer
, Michael Hauptmann
, et al.
·
Blood
·
46
Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing
2021
·
Amin Allahyar
, Mark Pieterse
, et al.
·
Nature Communications
·
43
PDF
ALL-tRNAseq enables robust tRNA profiling in tissue samples
2023
·
Chantal Scheepbouwer
, Ernesto Aparicio-Puerta
, et al.
·
Genes & Development
·
39
PDF
Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma
2018
·
Matias Mendeville
, Margaretha G. M. Roemer
, et al.
·
Blood
·
36
PDF
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
2022
·
G. Tjitske Los-de Vries
, Wendy B. C. Stevens
, et al.
·
Blood Advances
·
34
PDF
Breast Implant Prevalence in the Dutch Female Population Assessed by Chest Radiographs
2019
·
Mintsje de Boer
, Michele van Middelkoop
, et al.
·
Aesthetic Surgery Journal
·
29
PDF
Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell
2023
·
G. Tjitske Los-de Vries
, Phylicia Stathi
, et al.
·
Cancer Research
·
22
PDF
Interobserver variation in CD 30 immunohistochemistry interpretation; consequences for patient selection for targeted treatment
2018
·
Lianne Koens
, Peter M van de Ven
, et al.
·
Histopathology
·
16
PDF
Rituximab‐ PECC induction followed by 90Y‐ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT : results from a phase II HOVON study
2019
·
Pieternella J. Lugtenburg
, Josee M. Zijlstra
, et al.
·
British Journal of Haematology
·
10
Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma
2023
·
Margaretha G.M. Roemer
, Tim van de Brug
, et al.
·
iScience
·
9
PDF
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma
2025
·
Matías S. Mendeville
, Jurriaan Janssen
, et al.
·
Nature Communications
·
8
PDF
Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies
2022
·
Max V. Boot
, Michael Schaapveld
, et al.
·
Haematologica
·
5
PDF
ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2
2015
·
S. A. G. M. Cillessen
, N. J. Hijmering
, et al.
·
Haematologica
·
5
PDF
Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment
2022
·
Esther E. E. Drees
, Yvonne W. S. Jauw
, et al.
·
HemaSphere
·
2
Abstract PO-45: Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing
2020
·
Amin Allahyar
, Mark Pieterse
, et al.
·
Blood Cancer Discovery
·
2
Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies
2019
·
Hilma J Van Der Horst
, A. Vera de Jonge
, et al.
·
Blood
·
2
First Report on a Successful Screening Program for MYC Rearrangements and a Prospective Clinical Trial Based on MYC Rearrangement in Newly Diagnosed DLBCL Patients in the Netherlands
2017
·
Martine E.D. Chamuleau
, Marcel Nijland
, et al.
·
Blood
·
2
Specific Genetic Alterations Characterize Seroma‐ and Tumor‐type Breast‐implant Associated Anaplastic Large Cell Lymphoma (bia‐alcl) as a Distinct Disease Entity
2019
·
B. Ylstra
, G.T. Los‐de Vries
, et al.
·
Hematological Oncology
·
1
PDF
Sa1278 Bortezomib Restores Defective Apoptosis by Upregulation of Noxa in Enteropathy-Associated T-Cell Lymphoma
2013
·
Laura R. de Baaij
, Marijn Radersma
, et al.
·
Gastroenterology
·
1
Show more works
View as search
Works count:
54
Citation count:
928
H-index:
14
I10-index:
15
Year
Topic
Type
